A comprehensive, up-to-date and high-quality review of Veterinary Oncologic and Reproductive Pharmacology for professionals who aspire to excellence in their field"

Throughout this Postgraduate diploma, we will identify the therapeutic groups and their mechanisms of action and we will discuss, throughout the module, hormones and their therapeutic, regulatory, diagnostic and even fraudulent use.
 
The pharmacology of reproduction, gestation and parturition in different species, both production and domestic, will be discussed. 

Anti-infective pharmacology is characterized by the study of drugs that have to act on cells other than those of the veterinary patient, which are intended to be eliminated in their entirety. They are capable of destroying or inhibiting the development of live germs that cause infections by acting through different pharmacological targets. 

Antineoplastic pharmacology can act by destroying or inhibiting the development of tumor cells. TECH considers this module of great interest, due to the increasing incidence of neoplastic diseases in animals, with a greater emphasis on small animals.  

A complete education in the use of veterinary drugs in cases of reproductive and oncological diseases"

This Postgraduate diploma in Veterinary Oncologic and Reproductive Pharmacology  contains the most complete and up-to-date educational program on the market. The most important features include:

• Innovative and up-to-date diagnostic techniques in infectious diseases and their application in daily clinical practice, including the use of cytology as a diagnostic tool in these diseases.
• The most frequent and not so frequent pathologies of infectious origin in dogs from a practical and completely up-to-date point of view
• Infectious Pathologies oriented to the Feline Species, dealing extensively with all those of this species
• Vision "One Health", in which Zoonoses and their implications for public health will be reviewed
• Most frequent Infectious Pathologies of Dogs and Cats in the Tropics, with focus on Latin America. At present, there are no more exotic diseases and they should be included by the clinician in the differential diagnosis when the epidemiology allows to suspect them
• Prevention and management of all infectious diseases, including clinical, home and community settings

A revolutionary program for its ability to reconcile the highest quality of learning with the most complete online Education"

Its teaching staff includes professionals belonging to the field of Veterinary Medicine, who bring to this training the experience of their work, as well as renowned specialists from reference societies and prestigious universities.
  
The multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide immersive training programmed to train in real situations. 
 
This program is designed around Problem-Based Learning, whereby the specialist must try to solve the different professional practice situations that arise throughout the program. For this purpose, the professional will be assisted by an innovative interactive video system created by renowned and experienced psychology experts.     

A great opportunity for the veterinary medicine professional to advance his or her competencies and catch up on all the latest developments in pharmacological approaches"

Learn efficiently with a real qualification objective, with this Postgraduate diploma, unique for its quality and price, in the online teaching market"

This Postgraduate diploma provides all the necessary knowledge to be able to practice Pharmacology in Veterinary Medicine in the best possible way. It is important to take into account that the contents allow the student to obtain specialized knowledge of pharmacology, as well as the ability to deal with different solutions for veterinary pathologies. A complete and accessible education path that will make a difference in the student´s career progression. 

A complete educational program that will provide you with the comprehensive education necessary to intervene as a specialist in the theoretical and practical aspects of Veterinary Oncologic and Reproductive Pharmacology"

Module 1. Pharmacology of the Endocrine and Reproductive System. Reproductive Disorders 
 

1.1. Endocrine System Pharmacology

1.1.1. Introduction 
1.1.2. Classification of Hormones of Pharmacological Interest 
1.1.3. Mechanisms of Action  
1.1.4. General Information on Hormone Therapeutics 

1.2. Hormones Involved in Metabolism and Electrolyte Balance

1.2.1. Adrenal Pharmacology: Mineralocorticoids and Glucocorticoids 
1.2.2. Pharmacological Actions 
1.2.3. Therapeutic Uses 
1.2.4. Side effects: 

1.3. Thyroid and Parathyroid Pharmacology

1.3.1. Thyroid Hormones 
1.3.2. Antithyroid Drugs 
1.3.3. Calcemia Regulation 

1.3.3.1. Calcitonin 
1.3.3.2. Parathormone 

1.4. Pharmacology of the Pancreas

1.4.1. Insulin 
1.4.2. Oral Hypoglycemic Agents 
1.4.3. Glucagon 

1.5. Hormones Involved in Reproduction

1.5.1. Introduction  
1.5.2. Gonadotropin-Releasing Hormone 
1.5.3. Pituitary and Non-pituitary Gonadotropins 

1.6. Sex Hormones

1.6.1. Androgens  
1.6.2. Estrogens 
1.6.3. Progestogens 
1.6.4. Actions in the Organism 
1.6.5. Clinical Uses 
1.6.6. Toxicity 

1.7. Luteolytic Drugs

1.7.1. Prostaglandins 
1.7.2. Oxytocic Drugs: Oxytocin 
1.7.3. Pharmacology of Lactation 

1.8. Diagnostic Hormones in Veterinary Medicine

1.8.1. Diagnostic Tests 

1.8.1.1. Hormones of Diagnostic Utility in Large Animals: Production Animals 
1.8.1.2. Testosterone 
1.8.1.3. Estrogens 
1.8.1.4. Progesterone 
1.8.1.5. Iodothyronines 

1.8.2. Hormones of Diagnostic Utility in Companion Animals 

1.8.2.1. Reproductive Hormones 
1.8.2.2. Metabolic Hormones 

1.9. Pharmacology of the Reproductive System

1.9.1. Introduction  
1.9.2. Classification of Hormones of Pharmacological Interest 
1.9.3. Mechanisms of action 
1.9.4. Therapeutics in General  

1.10. Pharmacology of Reproductive Disorders

1.10.1.    Main Reproductive Disorders 

1.10.1.1. Large Animals: Production Animals 
1.10.1.2. Companion Animals 

1.10.2. Estrous Cycle Control 
1.10.3. Melatonin

Module 2. Antiseptics and Chemotherapeutics I 

2.1. Introduction. Definition of Antiseptic and Chemotherapeutic. Antiseptics

2.1.1. Introduction 
2.1.2. Antiseptic and Disinfectant Concept 
2.1.3. Factors Affecting the Potency of Antiseptics and Disinfectants 
2.1.4. Characteristics of an Ideal Antiseptic and Disinfectant 
2.1.5. Classification of Disinfectants and Antiseptics 
2.1.6. Main Antiseptics and Disinfectants for Clinical Use 

2.1.6.1. Alcohol 
2.1.6.2. Biguanides 
2.1.6.3. Halogenated Products 
2.1.6.4. Peroxygens   
2.1.6.5. Other Antiseptics  

2.2. Introduction to Antimicrobial Therapy.  Types of Antibiotics. Rational Use

2.2.1. Introduction 
2.2.2. Historical Review of Antimicrobial Therapy 
2.2.3. Side Effects: 
2.2.4. Principles of Antibiotherapy 
2.2.5. Resistance: Types and Mechanisms of Occurrence 
2.2.6. Waiting Times 
2.2.7. Requirements for an Antimicrobial 
2.2.8. Classification of Antimicrobials  

2.2.8.1. According to its Spectrum 
2.2.8.2. According to its Effect  
2.2.8.3. According to its Mechanism of Action  
2.2.8.4. According to its Chemical Group 
2.2.8.5. Depending on the Microorganism Affected 

2.2.9. Criteria to be Followed in the Selection of a Drug 

2.3. Antimicrobials that Act Against the Bacterial Wall. Antibiotics that Inhibit Protein Synthesis

2.3.1. Antibiotics Acting Against the Bacterial Wall 

2.3.1.1. General Aspects 
2.3.1.2. Betalactams (b-lactams) 

2.3.1.2.1. Penicillin 
2.3.1.2.2. Cephalosporins 
2.3.1.2.3. Vancomycin and Bacitracin 

2.3.2. Antibiotics that Inhibit Protein Synthesis 

2.3.2.1. Aminoglycosides 
2.3.2.2. Tetracyclines 
2.3.2.3. Chloramphenicol and Derivatives 
2.3.2.4. Macrolides and Lincosamides 

2.3.3. β-Lactamase Inhibitors 

2.4. Antibiotics that Act on the Synthesis of Nucleic Acids. Antibiotics Acting on the Bacterial Membrane

2.4.1. Fluroquinolones 
2.4.2. Nitrofurans 
2.4.3. Nitroimidazoes 
2.4.4. Sulfamides 
2.4.5. Polymyxins and Thyrotricins 

2.5. Antifungal

2.5.1. General Description of the Mycotic Structure 
2.5.2. Classification of Antifungal Agents by Chemical Structure 
2.5.3. Systemic Antifungals 
2.5.4. Topical Antifungals 

2.6. Antivirals 

2.6.1. Objective of Antiviral Chemotherapy 
2.6.2. Groups of Antivirals According to their Origin, Chemistry, Pharmacological Action, Pharmacokinetics, Pharmacodynamics, Posology, Therapeutic Uses, Adverse                  Reactions, Contraindications, Interactions and Pharmaceutical Forms 

2.6.2.1. Inhibitors of RNA and DNA Synthesis 
2.6.2.2. Purine Analogs 
2.6.2.3. Pyrimidine Analogs 
2.6.2.4. Reverse Transcriptase Inhibitors 
2.6.2.5. Interferons. 

2.7. Antiparasitics II

2.7.1. Introduction to Antiparasitic Therapy 
2.7.2. Importance of Dewormers in Veterinary Medicine 
2.7.3. General Concepts: Antinematodic, Anticestodic, Antitrematodic, Antiprotozoal, Ectoparasiticide and Endectocide. 

2.8. Antiparasitics for Internal or Endoparasitic Use

2.8.1. Antinematodes 
2.8.2. Antistatics 
2.8.3. Antitrematodic 
2.8.4. Antiprotozoals 

2.9. Antiparasitics for External or Ectoparasitic Use

2.9.1. Introduction to External Parasites 
2.9.2. Antiparasitics II  

2.10. Antiparasitics for Internal and External Use or Endectocides

2.10.1. Introduction  
2.10.2. Macrocyclic Lactones 
2.10.3. Main Combinations of Endectocide Use 

Module 3. Chemotherapy II: Antineoplastic Drugs 

3.1. Introduction to Antineoplastic Therapy

3.1.1. Cancer in Veterinary Medicine: Pathophysiology and Etiology of Cancer 
3.1.2. Antineoplastic Treatment Approach: Drug Posology  
3.1.3. Administration of Chemotherapy Drugs 

3.1.3.1. Care in the Application of Chemotherapeutic Agents 
3.1.3.2. Standards and Instructions for Chemotherapy Application: Preparation During Preparation/Administration of Cytotoxic Drugs 

3.2. Palliative Antineoplastic Pharmacology Introduction to Special Antineoplastic Pharmacology

3.2.1. Introduction to Palliative Antineoplastic Pharmacology: oncologic pain control/evaluation. Pharmacological Principles for Palliative Pain Management. Nutritional                 Management of the Oncology Patient 
3.2.2. Non-Steroidal Analgesics 
3.2.3. Opioids 
3.2.4. Others: NMDA Antagonists, Bisphosphonates, Tricyclic Antidepressants, Anticonvulsants, Nutraceuticals, Cannabidiol 
3.2.5. Introduction to Special Antineoplastic Pharmacology. Main Families of Antineoplastic Drugs 

3.3. Family 1: Alkylating Agents

3.3.1. Introduction 
3.3.2. Nitrogen Mustards: Cyclophosphamide, Chlorambucil and Melphalan 
3.3.3. Nitrosoureas: Lomustine/Procarbazine 
3.3.4. Others: Hydroxyurea 
3.3.5. Main Uses in Veterinary Medicine 

3.4. Family 2: Antimetabolites

3.4.1. Introduction 
3.4.2. Folic Acid Analogs (antifolates): Methotrexate 
3.4.3. Purine Analogues: Azathioprine
3.4.4. Pyrimidine Analogues: Cytosine Arabinoside, Gentabicin, 5-Fluorouracil 
3.4.5. Main Uses in Veterinary Medicine 

3.5. Family 3: Antibiotics

3.5.1. Introduction 
3.5.2. Anthracycline-Derived Antibiotics (doxorubicin/other anthracyclines) and Non-Anthracycline-Derived Antibiotics (actinomycin-d, mitoxantrone, bleomycin) 
3.5.3. Main Uses in Veterinary Medicine 

3.6. Family 4: Antineoplastics of Plant Origin

3.6.1. Introduction  
3.6.2. Alkaloids: History/Antitumor Activity. Vinca Alkaloids
3.6.3. Epipododiphyllotoxin-Derived Ligands 
3.6.4. Camptothecin Alkaloid Analogs 
3.6.5. Main Uses in Veterinary Medicine 

3.7. Family 5: Tyrosine Kinase Inhibitors

3.7.1. Introduction 
3.7.2. Protein Kinases: Non-Receptor Tyrosine Kinase Proteins (NRTK; Receptor Tyrosine Kinase RTK) 
3.7.3. Toceranib 
3.7.4. Masitinib 
3.7.5. Main Uses in Veterinary Medicine 

3.8. Platinum Derivatives

3.8.1. Introduction 
3.8.2. Carboplatin 
3.8.3. Cisplatin 
3.8.4. Main Uses in Veterinary Medicine 

3.9. Miscellaneous. Monoclonal Antibodies. Nanotherapy. L-asparaginase

3.9.1. Introduction 
3.9.2. L-asparaginase 
3.9.3. Monoclonal Antibodies 
3.9.4. Tigylanol Toglate (stelfonta) 
3.9.5. Immunotherapy 
3.9.6. Metronomic Therapy 

3.10. Toxicity of Antineoplastic Drugs

3.10.1. Introduction 
3.10.2. Hematological Toxicity 
3.10.3. Gastrointestinal Toxicity 
3.10.4. Cardiotoxicity
3.10.5. Urinary Toxicity 
3.10.6. Specific Toxicities: Hepatic, Neurological, Cutaneous, Hypersensitivity, Breed/Species Associated. 
3.10.7. Pharmacological Interactions 

This program will allow you to advance in your career comfortably"